Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Xenon Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
XENE
Nasdaq
2834
http://www.xenon-pharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Xenon Pharmaceuticals Inc
Xenon Pharmaceuticals (XENE) Reports Q1 Loss, Misses Revenue Estimates
- May 10th, 2022 9:45 pm
Xenon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
- May 10th, 2022 8:01 pm
Syndax Pharmaceuticals (SNDX) Reports Q1 Loss, Lags Revenue Estimates
- May 9th, 2022 10:25 pm
Puma Biotech (PBYI) Reports Q1 Loss, Misses Revenue Estimates
- May 5th, 2022 10:05 pm
G1 Therapeutics (GTHX) Reports Q1 Loss, Tops Revenue Estimates
- May 4th, 2022 11:45 am
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2022 Financial Results and Provide Corporate Update
- May 3rd, 2022 8:01 pm
Xenon Pharmaceuticals Announces Initiation of Phase 2 Clinical Trial to Evaluate XEN1101 as a Treatment for Major Depressive Disorder (MDD)
- May 3rd, 2022 12:00 pm
Xenon Pharmaceuticals Inc.'s (NASDAQ:XENE) Intrinsic Value Is Potentially 100% Above Its Share Price
- Apr 29th, 2022 6:25 pm
Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
- Apr 25th, 2022 8:01 pm
Xenon Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference
- Apr 4th, 2022 8:01 pm
Xenon Pharmaceuticals to Present at Stifel 2022 CNS Days
- Mar 22nd, 2022 8:01 pm
Xenon Pharmaceuticals (XENE) Reports Q4 Loss, Lags Revenue Estimates
- Mar 1st, 2022 10:25 pm
Xenon Pharmaceuticals Reports 2021 Financial Results and Provides Corporate Update
- Mar 1st, 2022 9:01 pm
Tabula Rasa Healthcare (TRHC) Reports Q4 Loss, Tops Revenue Estimates
- Feb 25th, 2022 1:10 am
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2021 Financial Results and Provide Corporate Update
- Feb 22nd, 2022 9:01 pm
Blueprint Medicines (BPMC) Reports Q4 Loss, Tops Revenue Estimates
- Feb 16th, 2022 1:15 pm
Xenon Pharmaceuticals to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
- Feb 14th, 2022 9:01 pm
How Did Hedge Funds’ Xenon Pharmaceuticals Inc (XENE) Bets Fare?
- Feb 6th, 2022 9:40 pm
Accel Wealth Management Buys Vanguard Total Stock Market ETF, iShares Core Dividend Growth ETF, ...
- Jan 18th, 2022 10:38 pm
Xenon Pharmaceuticals Announces Collaboration with Neurocrine Biosciences Achieves $15.0 Million Regulatory Milestone
- Jan 12th, 2022 1:00 pm
Scroll